Clinical Performance of Bioglass‐Enriched Resin Modified Glass Ionomer in Sealing Moderate Carious Lesions: An 18‐Month Split‐Mouth Clinical Trial

Key Points

• To assess the performance of bioglass-enriched resin modified glass ionomer (RMGIC) in sealing moderate carious lesions.
• Conducted an 18-month split-mouth clinical trial
• Compared retention and restoration quality between bioglass-enriched and standard RMGIC
• Monitored caries progression and arrestment levels over time
• No significant changes in retention between bioglass-enriched RMGIC and standard RMGIC
• Restoration quality remained consistent across both materials
• Caries progression and arrestment levels did not differ after 18 months

Abstract